FDA Recalls Blood Pressure Medicine

Due to the presence of excessive amounts of nitrosamines, Aurobindo Pharma USA is recalling two lots of its quinapril and hydrochlorothiazide tablets.

These are molecules found in low amounts in water and meals such as meats, dairy products, and vegetables, however nitrosamines may raise the risk of cancer.

According to Aurobindo's voluntary recall released by the FDA, people can get sick if exposed to them at above-safe levels for a long time.

Quinapril and hydrochlorothiazide treat hypertension. The recall includes two lots of Aurobindo's 20 mg/12.5 mg, both with expiration dates until January 2023.

The tablets have the letter "D" printed on one side and the number "19" printed on the other side, and they are round and pink in color.

If you are taking this medicine, you should consult with your doctor before stopping it, according to the FDA's notice.

Untreated high blood pressure can increase the risk of stroke, heart attack, and other major health issues or medical crises.

Aurobindo hasn't received any recall-related adverse event reports. Consumers with medical questions about the recall can call 866-850-2876  or email pvg@aurobindousa.com 

Other blood pressure drugs under various names have been recalled this year due to the same concern about excessive nitrosamine levels.